PreDxion Bio Company
PreDxion Bio aims to revolutionize critical care medicine by providing ICU doctors with actionable patient immune function data
Founded Date:
2016-02-02
Industry:
P4 Medicine
Estimated Revenue:
Less than $1M
Last Funding Type:
Seed
Total Funding:
$120K
Headquarters:
Others
Technology:
Other
Investor Type:
For Profit
Investors Number:
3
Employee Number:
1-10
Funding Status:
Seed